VEGFA and tumour angiogenesis
Top Cited Papers
- 31 January 2013
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 273 (2), 114-127
- https://doi.org/10.1111/joim.12019
Abstract
Claesson-Welsh L, Welsh M (Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden and Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden). VEGFA and tumour angiogenesis (Review). J Intern Med 2013; 273: 114-127. In this review we summarize the current understanding of signal transduction downstream of vascular endothelial growth factor A (VEGFA) and its receptor VEGFR2, and the relationship between these signal transduction pathways and the hallmark responses of VEGFA, angiogenesis and vascular permeability. These physiological responses involve a number of effectors, including extracellular signal-regulated kinases (ERKs), Src, phosphoinositide 3 kinase (PI3K)/Akt, focal adhesion kinase (FAK), Rho family GTPases, endothelial NO and p38 mitogen-activated protein kinase (MAPK). Several of these factors are involved in the regulation of both angiogenesis and vascular permeability. Tumour angiogenesis primarily relies on VEGFA-driven responses, which to a large extent result in a dysfunctional vasculature. The reason for this remains unclear, although it appears that certain aspects of the VEGFA-stimulated angiogenic milieu (high level of microvascular density and permeability) promote tumour expansion. The high degree of redundancy and complexity of VEGFA-driven tumour angiogenesis may explain why tumours commonly develop resistance to anti-angiogenic therapy targeting VEGFA signal transduction.Keywords
Funding Information
- Swedish Research Council
- Swedish Cancer Foundation
- Knut and Alice Wallenberg Foundation
This publication has 133 references indexed in Scilit:
- Axl is essential for VEGF-A-dependent activation of PI3K/AktThe EMBO Journal, 2012
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and ProgressionCancer Cell, 2011
- VEGF Receptor 2 Endocytic Trafficking Regulates Arterial MorphogenesisDevelopmental Cell, 2010
- The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological ImplicationsDevelopmental Cell, 2009
- Chapter 2 PI3K/PTEN Signaling in Angiogenesis and TumorigenesisAdvances in Cancer Research, 2009
- Global Impact of Oncogenic Src on a Phosphotyrosine ProteomeJournal of Proteome Research, 2008
- Vascular permeability, vascular hyperpermeability and angiogenesisAngiogenesis, 2008
- VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2Experimental Cell Research, 2007
- AMP-activated protein kinase mediates VEGF-stimulated endothelial NO productionBiochemical and Biophysical Research Communications, 2007
- Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycinCancer Cell, 2006